Literature DB >> 23333101

Clinical significance of Pneumocystis jiroveci in patients with active tuberculosis.

Kelvin K W To1, Ivan F N Hung, Ting Xu, Rosana W S Poon, Whitney C T Ip, Patrick T W Li, Clara P Y Li, Susanna K P Lau, Wing-Cheong Yam, Kwok-Hung Chan, Kwok-Yung Yuen.   

Abstract

Pneumocystis colonization has been associated with airway inflammation and obstruction. We conducted a retrospective cohort study to investigate the clinical significance of Pneumocystis in the airway of patients with active tuberculosis. Of the 108 respiratory specimens tested positive for M. tuberculosis by polymerase chain reaction (PCR), 11 (10.2%) were also positive for Pneumocystis by PCR. Compared with patients tested negative for Pneumocystis, those with Pneumocystis had a higher serum alanine transaminase level, a greater likelihood of requiring oxygen supplementation, and a worse 30-day mortality. The proportion of patients with chronic obstructive pulmonary disease was not significantly different between the 2 groups, but lung malignancy was more prevalent among patients with Pneumocystis. Multivariate analysis showed that Pneumocystis was independently associated with oxygen supplementation. Our study has shown an association between the detection of Pneumocystis in lower respiratory tract specimens and greater impairment of pulmonary function among patients with active tuberculosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333101     DOI: 10.1016/j.diagmicrobio.2012.11.016

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

1.  Use of nasopharyngeal aspirate for diagnosis of pneumocystis pneumonia.

Authors:  Kelvin K W To; Sally C Y Wong; Ting Xu; Rosana W S Poon; Ka-Yi Mok; Jasper F W Chan; Vincent C C Cheng; Kwok-Hung Chan; Ivan F N Hung; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

2.  Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Authors:  Florence Robert-Gangneux; Sorya Belaz; Matthieu Revest; Pierre Tattevin; Stéphane Jouneau; Olivier Decaux; Sylviane Chevrier; Yves Le Tulzo; Jean-Pierre Gangneux
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

Review 3.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.